Reminder: You have 1 Unclaimed Bonus ($5,000 value)

This is a big deal for us – and for you too, I hope. But you'll need to act by tomorrow. In short, we're offering you free access to our new quant system, as an urgent response to the recent market selloff. [Stansberry Digest] Dear Reader, This is a big deal for us – and for you too, I hope. But you'll need to act by tomorrow. In short, we're offering you free access to our new quant system, as an urgent response to the recent market selloff. [Our quant strategy]( and analyst recently got endorsed by a legendary quant investor, who manages $4.5 billion. It's easy to see why... It crushed the S&P 500 since we first introduced it back on January 25, even during a raging bull market. In June alone, it nearly doubled the market's return. And it crushed Microsoft and Apple, even during this year's AI boom. In fact, it could have turned every $100,000 of your money into $254,000 since we first set it loose in our backtest, beating the market with 91% accuracy, even during the 2022 crash! Our system is normally $5,000... But through a special offer expiring tomorrow, we're inviting you to [claim one free year of access and a full suite of bonuses as part of a special offer.]( We think you'll love the system... EXPI scored as a "BUY" before it rose 1,561%RMBS scored as a "BUY" before it rose 387%ENPH scored as a "BUY" before it rose 166%CAR scored as a "BUY" before it rose 218%CROX scored as a "BUY" before it rose 1,916%BLDR scored as a "BUY" before it rose 476%LPG scored as a "BUY" before it rose 225%AMR scored as a "BUY" before it rose 146%AEHR scored as a "BUY" before it rose 214%ADP scored as a "BUY" before it rose 816%WRB scored as a "BUY" before it rose 415%TPL scored as a "BUY" before it rose 439%SMCI scored as a "BUY" before it rose 917%MSB scored as a "BUY" before it rose 544%FICO scored as a "BUY" before it rose 816%SNPS scored as a "BUY" before it rose 856%ELF scored as a "BUY" before it rose 715%MED scored as a "BUY" before it rose 143%CPRX scored as a "BUY" before it rose 315%TXN scored as a "BUY" before it rose 101%LSCC scored as a "BUY" before it rose 395%MSFT scored as a "BUY" before it rose 1,179%MCD scored as a "BUY" before it rose 276%AZO scored as a "BUY" before it rose 187%STZ scored as a "BUY" before it rose 628%XPEL scored as a "BUY" before it rose 1,443%AXP scored as a "BUY" before it rose 181%ISRG scored as a "BUY" before it rose 122%VMW scored as a "BUY" before it rose 101%CPRT scored as a "BUY" before it rose 127%MANH scored as a "BUY" before it rose 169%KLAC scored as a "BUY" before it rose 728%DECK scored as a "BUY" before it rose 402%CDNS scored as a "BUY" before it rose 1,019% This works on the downside, too. For example: NOVN scored as "JUNK" before it fell 100%INPX scored as "JUNK" before it fell 99%GWGH scored as "JUNK" before it fell 99%SRNE scored as "JUNK" before it fell 99%RELI scored as "JUNK" before it fell 97%SVFD scored as "JUNK" before it fell 95%JAGX scored as "JUNK" before it fell 99%VINO scored as "JUNK" before it fell 99%OLB scored as "JUNK" before it fell 81%RCON scored as "JUNK" before it fell 84% Just keep in mind: You should act by tomorrow if you're interested before we re-close the doors on this offer forever. Until then, [click here to learn more.]( Regards, Matt Weinschenk Director of Research, Stansberry Research Published by Stansberry Research. You have received this e-mail as part of your subscription to Stansberry Digest. If you no longer wish to receive special offers from Stansberry Digest, [click here](. You're receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized financial advice. © 2024 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 [stansberryresearch.com](.